Anticoagulation for left ventricular thrombi secondary to COVID—Is 3 months too long?

The length of anticoagulation for thrombotic events related to COVID‐19 is unknown. We present a patient with COVID‐19 complicated by a thrombotic anterior STEMI and multiple left ventricular (LV) thrombi that resolved after 8 weeks of anticoagulation. We suggest a shorter length of anticoagulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Rimmy, Sachdeva, Amitoj, Del Cid Fratti, Juan, Mortoti, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207223/
https://www.ncbi.nlm.nih.gov/pubmed/35765294
http://dx.doi.org/10.1002/ccr3.5950
_version_ 1784729472562364416
author Garg, Rimmy
Sachdeva, Amitoj
Del Cid Fratti, Juan
Mortoti, Samuel
author_facet Garg, Rimmy
Sachdeva, Amitoj
Del Cid Fratti, Juan
Mortoti, Samuel
author_sort Garg, Rimmy
collection PubMed
description The length of anticoagulation for thrombotic events related to COVID‐19 is unknown. We present a patient with COVID‐19 complicated by a thrombotic anterior STEMI and multiple left ventricular (LV) thrombi that resolved after 8 weeks of anticoagulation. We suggest a shorter length of anticoagulation with COVID‐19‐related LV thrombus.
format Online
Article
Text
id pubmed-9207223
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92072232022-06-27 Anticoagulation for left ventricular thrombi secondary to COVID—Is 3 months too long? Garg, Rimmy Sachdeva, Amitoj Del Cid Fratti, Juan Mortoti, Samuel Clin Case Rep Case Report The length of anticoagulation for thrombotic events related to COVID‐19 is unknown. We present a patient with COVID‐19 complicated by a thrombotic anterior STEMI and multiple left ventricular (LV) thrombi that resolved after 8 weeks of anticoagulation. We suggest a shorter length of anticoagulation with COVID‐19‐related LV thrombus. John Wiley and Sons Inc. 2022-06-19 /pmc/articles/PMC9207223/ /pubmed/35765294 http://dx.doi.org/10.1002/ccr3.5950 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Garg, Rimmy
Sachdeva, Amitoj
Del Cid Fratti, Juan
Mortoti, Samuel
Anticoagulation for left ventricular thrombi secondary to COVID—Is 3 months too long?
title Anticoagulation for left ventricular thrombi secondary to COVID—Is 3 months too long?
title_full Anticoagulation for left ventricular thrombi secondary to COVID—Is 3 months too long?
title_fullStr Anticoagulation for left ventricular thrombi secondary to COVID—Is 3 months too long?
title_full_unstemmed Anticoagulation for left ventricular thrombi secondary to COVID—Is 3 months too long?
title_short Anticoagulation for left ventricular thrombi secondary to COVID—Is 3 months too long?
title_sort anticoagulation for left ventricular thrombi secondary to covid—is 3 months too long?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207223/
https://www.ncbi.nlm.nih.gov/pubmed/35765294
http://dx.doi.org/10.1002/ccr3.5950
work_keys_str_mv AT gargrimmy anticoagulationforleftventricularthrombisecondarytocovidis3monthstoolong
AT sachdevaamitoj anticoagulationforleftventricularthrombisecondarytocovidis3monthstoolong
AT delcidfrattijuan anticoagulationforleftventricularthrombisecondarytocovidis3monthstoolong
AT mortotisamuel anticoagulationforleftventricularthrombisecondarytocovidis3monthstoolong

Ejemplares similares